MedTrace Logo

Neurologic Stem Cell Treatment Study

NCT02795052 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-06-06

No results posted yet for this study

Summary

This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/

Conditions

Interventions

PROCEDURE

Intravenous and Intranasal BMSC

Autologous Bone Marrow Derived Stem Cells provided intravenous and intranasal (lower 1/3 of nose)

Sponsors & Collaborators

  • MD Stem Cells

    lead INDUSTRY

Principal Investigators

  • Steven Levy, MD · MD Stem Cells

  • Jeffrey Weiss, MD · Coral Springs, Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2026-07-31
Completion
2027-07-31

Countries

  • United States
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02795052 on ClinicalTrials.gov